• 1
    Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415419.
  • 2
    Krauter J, Gorlich K, Ottmann O, et al. Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias. J Clin Oncol 2003; 21: 44134422.
  • 3
    Schilz AJ, Kuhlcke K, Fauser AA, et al. MDR1 gene expression in NOD/SCID repopulating cells after retro-viral gene transfer under clinically relevant conditions. Mol Ther 2000; 2: 609618.
  • 4
    Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000; 288: 669672.
  • 5
    Schmidt M, Carbonaro DA, Speckmann C, et al. Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates. Nat Med 2003; 9: 463468.
  • 6
    Schiedlmeier B, Kuhlcke K, Eckert HG, et al. Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice. Blood 2000; 95: 12371248.
  • 7
    Laufs S, Gentner B, Nagy KZ, et al. Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells. Blood 2003; 101: 21912198.
  • 8
    Heid CA, Stevens J, Livak KJ, et al. Real time quantitative PCR. Genome Res 1996; 6: 986994.
  • 9
    Alizadeh M, Bernard M, Danic B, et al. Quantitative assessment of hematopoietic chimerism after bone-marrow transplantation by real-time quantitative polymerase chain reaction. Blood 2002; 99: 46184625.
  • 10
    Veldwijk MR, Topaly J, Laufs S, et al. Development and optimization of a real-time quantitative PCR-based method for the titration of AAV-2 vector stocks. Mol Ther 2002; 6: 272278.
  • 11
    Schiedlmeier B, Schilz AJ, Kuhlcke K, et al. Multidrug resistance 1 gene transfer can confer chemoprotection to human peripheral blood progenitor cells engrafted in immunodeficient mice. Hum Gene Ther 2002; 13: 233242.
  • 12
    Abonour R, Williams DA, Einhorn L, et al. Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells. Nat Med 2000; 6: 652658.
  • 13
    Fruehauf S, Veldwijk MR, Berlinghoff S, et al. Gene therapy for sarcoma. Cells Tissues Organs 2002; 172: 133144.
  • 14
    Eckert HG, Kuhlcke K, Schilz AJ, et al. Clinical scale production of an improved retroviral vector expressing the human multidrug resistance 1 gene (MDR1). Bone Marrow Transplant 2000; 25(suppl 2):114117.
  • 15
    Hildinger M, Abel KL, Ostertag W, et al. Design of 5′ untranslated sequences in retroviral vectors developed for medical use. J Virol 1999; 73: 40834089.
  • 16
    Fruehauf S, Breems DA, Knaan-Shanzer S, et al. Frequency analysis of multidrug resistance-1 gene transfer into human primitive hematopoietic progenitor cells using the cobblestone area-forming cell assay and detection of vector-mediated P-glycoprotein expression by rhodamine-123. Hum Gene Ther 1996; 7: 12191231.
  • 17
    Larochelle A, Vormoor J, Hanenberg H, et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med 1996; 2: 13291337.
  • 18
    Cashman JD, Lapidot T, Wang JC, et al. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood 1997; 89: 43074316.
  • 19
    Gothot A, van der Loo JC, Clapp DW, et al. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34+ cells in non-obese diabetic/severe combined immune-deficient mice. Blood 1998; 92: 26412649.
  • 20
    Akashi K, Traver D, Miyamoto T, et al. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 2000; 404: 193197.
  • 21
    Dick JE, Guenechea G, Gan OI, et al. In vivo dynamics of human stem cell repopulation in NOD/SCID mice. Ann N Y Acad Sci 2001; 938: 184190.
  • 22
    Guenechea G, Gan OI, Dorrell C, et al. Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat Immunol 2001; 2: 7582.
  • 23
    Horn PA, Thomasson BM, Wood BL, et al. Distinct hematopoietic stem/progenitor cell populations are responsible for repopulating NOD/SCID mice compared with nonhuman primates. Blood 2003; 102: 43294335.
  • 24
    Rosenthal A, Jones DS. Genomic walking and sequencing by oligo-cassette mediated polymerase chain reaction. Nucleic Acids Res 1990; 18: 30953096.
  • 25
    Schmidt M, Zickler P, Hoffmann G, et al. Polyclonal long-term repopulating stem cell clones in a primate model. Blood 2002; 100: 27372743.
  • 26
    Dynabeads M-280 Streptavidin. Dynal, Oslo, Norway.
  • 27
    Nolta JA, Dao MA, Wells S, et al. Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice. Proc Natl Acad Sci U S A 1996; 93: 24142419.
  • 28
    Bhatia M, Wang JC, Kapp U, et al. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A 1997; 94: 53205325.
  • 29
    Fruehauf S, Veldwijk MR, Kramer A, et al. Delineation of cell cycle state and correlation to adhesion molecule expression of human CD34+ cells from steady-state bone marrow and peripheral blood mobilized following G-CSF-supported chemotherapy. Stem Cells 1998; 16: 271279.
  • 30
    Brunning et al. WHO Classification of Tumors: Pathology & Genetics. Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2001:77.
  • 31
    Fruehauf S, Topaly J, Wilmes A, et al. Flow cytometric diagnostic of malignant hämatologic diseases. In: ZellerWJ, zur HausenH, eds. Onkologie. Landsberg/Lech: Ecomed Verlag, 2000:132.